Category: Press Release - Psilocybin Alpha

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:July 31, 2020
Post category:Press Release

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Post published:July 31, 2020
Post category:Press Release

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Post published:July 30, 2020
Post category:Press Release

Yield Growth Closes $1.4 Million Financing

Yield Growth Closes $1.4 Million Financing

Post published:July 30, 2020
Post category:Press Release

Palliative Canadians await August 4th decision on psilocybin mushroom approval – TheraPsil urges Health Minister to ‘do the right thing’

Palliative Canadians await August 4th decision on psilocybin mushroom approval – TheraPsil urges Health Minister to ‘do the right thing’

Post published:July 30, 2020
Post category:Press Release

Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness

Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness

Post published:July 29, 2020
Post category:Press Release

Empower Clinics Announces the Revocation of Cease Trade Order

Empower Clinics Announces the Revocation of Cease Trade Order

Post published:July 29, 2020
Post category:Press Release

MindMed Completes Dosing 18-MC Phase 1 Study

MindMed Completes Dosing 18-MC Phase 1 Study

Post published:July 28, 2020
Post category:Press Release

Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent

Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent

Post published:July 27, 2020
Post category:Press Release

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

Post published:July 25, 2020
Post category:Press Release

End of content

No more pages to load

We provide information, research, news and interviews from the emergent psychedelic sector in one place. Cut through the ‘shroom stock’ noise with Psilocybin Alpha.

Quick Links

Shroom Stocks and Companies

Learn about Psilocybin

Latest News and Updates

Where to Buy Shroom Stocks

Get in Touch

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Contact Disclaimer Terms of Service Privacy Policy Twitter

© Psilocybin Alpha 2020